Angelos Papadimitriou, a director at $CGNX, sold 4,150 shares of the company on 02-23-2026 for an estimated $230,658. We received data on the trade from a recent SEC filing. This was a sale of approximately 20.4% of their shares of this class of stock. Following this trade, they now own 16,222 shares of this class of $CGNX stock.
$CGNX Insider Trading Activity
$CGNX insiders have traded $CGNX stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $CGNX stock by insiders over the last 6 months:
- ROBERT WILLETT has made 0 purchases and 4 sales selling 185,904 shares for an estimated $10,796,896.
- JOERG KUECHEN (Head of Corporate M&A) has made 0 purchases and 4 sales selling 61,900 shares for an estimated $3,468,385.
- LAURA ANN MACDONALD (VP and PAO) has made 0 purchases and 3 sales selling 17,547 shares for an estimated $970,523.
- CARL GERST (EVP, Global Sales and Products) has made 0 purchases and 2 sales selling 14,336 shares for an estimated $802,021.
- ANGELOS PAPADIMITRIOU sold 4,150 shares for an estimated $230,658
- SHEILA MARIE DIPALMA (EVP, Employee Services) has made 0 purchases and 2 sales selling 4,002 shares for an estimated $180,150.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CGNX Hedge Fund Activity
We have seen 254 institutional investors add shares of $CGNX stock to their portfolio, and 298 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 10,471,400 shares (+173138.2%) to their portfolio in Q4 2025, for an estimated $376,760,971
- ALYESKA INVESTMENT GROUP, L.P. added 1,900,718 shares (+inf%) to their portfolio in Q4 2025, for an estimated $68,387,833
- PICTET ASSET MANAGEMENT HOLDING SA added 1,529,010 shares (+27.9%) to their portfolio in Q4 2025, for an estimated $55,013,779
- SWEDBANK AB removed 1,400,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $50,371,999
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,258,629 shares (+31.0%) to their portfolio in Q4 2025, for an estimated $45,285,471
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,113,868 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $40,076,970
- BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. added 1,032,175 shares (+65244.9%) to their portfolio in Q4 2025, for an estimated $37,137,656
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CGNX Revenue
$CGNX had revenues of $252.3M in Q4 2025. This is an increase of 9.86% from the same period in the prior year.
You can track CGNX financials on Quiver Quantitative's CGNX stock page.
$CGNX Analyst Ratings
Wall Street analysts have issued reports on $CGNX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 12/16/2025
- JP Morgan issued a "Underweight" rating on 12/03/2025
- Needham issued a "Buy" rating on 10/31/2025
- Barclays issued a "Overweight" rating on 10/31/2025
To track analyst ratings and price targets for $CGNX, check out Quiver Quantitative's $CGNX forecast page.
$CGNX Price Targets
Multiple analysts have issued price targets for $CGNX recently. We have seen 8 analysts offer price targets for $CGNX in the last 6 months, with a median target of $64.0.
Here are some recent targets:
- Matthew Summerville from DA Davidson set a target price of $55.0 on 02/17/2026
- Joe Ritchie from Goldman Sachs set a target price of $68.0 on 02/17/2026
- Helen Fang from HSBC set a target price of $68.0 on 02/17/2026
- Ken Newman from Keybanc set a target price of $70.0 on 02/13/2026
- Guy Hardwick from Barclays set a target price of $61.0 on 02/13/2026
- James Ricchiuti from Needham set a target price of $67.0 on 02/12/2026
- Jamie Cook from Truist Securities set a target price of $42.0 on 12/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
